BRAINTREE, Mass., March 25, 2019 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and full fiscal year 2019 financial results at 6:00 am ET on Tuesday, May 7, 2019. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 7, 2019.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 4378487
A live webcast of the call can be accessed on Haemonetics’ investor relations website. Webcast Link: https://edge.media-server.com/m6/p/299h3spu
Webcast replay will be available from May 7, 2019 after 10:00 am ET.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Gerry Gould, VP-Investor Relations
Olga Vlasova, Sr. Mgr.-Investor Relations
SOURCE Haemonetics Corporation